Genetically modified dendritic cells in cancer immunotherapy: a better tomorrow?
MR Shurin, M Gregory, JC Morris… - Expert Opinion on …, 2010 - Taylor & Francis
Importance of the field: Dendritic cells (DC) are powerful antigen-presenting cells that induce
and maintain primary cytotoxic T lymphocyte (CTL) responses directed against tumor …
and maintain primary cytotoxic T lymphocyte (CTL) responses directed against tumor …
Naturally circulating dendritic cells to vaccinate cancer patients
Dendritic cell-based immunotherapy is a promising strategy against cancer that appears to
be feasible, safe and to induce potent tumor-specific immune responses. The use of …
be feasible, safe and to induce potent tumor-specific immune responses. The use of …
The evolving role of dendritic cells in cancer therapy
EJ Ilett, RJD Prestwich, AA Melcher - Expert Opinion on Biological …, 2010 - Taylor & Francis
Importance of the field: Dendritic cells (DC) are a clear choice for use in cancer
immunotherapy, and much research has focused on generating DC for clinical use …
immunotherapy, and much research has focused on generating DC for clinical use …
Clinical applications of dendritic cell cancer vaccines
J Baar - The Oncologist, 1999 - academic.oup.com
It has been more than 100 years since Dr. William B. Coley reported the regression of
tumors in some patients who had been injected with bacterial extracts [1]. Since this early …
tumors in some patients who had been injected with bacterial extracts [1]. Since this early …
Current approaches in dendritic cell generation and future implications for cancer immunotherapy
The discovery of tumor-associated antigens, which are either selectively or preferentially
expressed by tumors, together with an improved insight in dendritic cell biology illustrating …
expressed by tumors, together with an improved insight in dendritic cell biology illustrating …
Human dendritic cells: natural adjuvants in antitumor immunotherapy.
M Di Nicola, A Anichini, R Mortarini… - Cytokines, cellular & …, 1998 - europepmc.org
Although T-cell-defined tumor antigens have recently been identified in several tumors,
human neoplastic cells are considered to be poorly immunogenic. The development of …
human neoplastic cells are considered to be poorly immunogenic. The development of …
Dendritic cells: development, function and potential use for cancer immunotherapy
D Avigan - Blood reviews, 1999 - Elsevier
Dendritic cells (DC) are potent antigen presenting cells that are essential for the initiation of
primary immune responses. They richly express MHC, costimulatory and adhesion …
primary immune responses. They richly express MHC, costimulatory and adhesion …
Dendritic cell immunotherapy: mapping the way
Dendritic cells (DCs) are the professional antigen-presenting cells of the immune system,
with the potential to either stimulate or inhibit immune responses. Exploiting the immune …
with the potential to either stimulate or inhibit immune responses. Exploiting the immune …
Dendritic cell-based vaccines: from mouse models to clinical cancer immunotherapy
MWJ Schreurs, AAO Eggert, CJA Punt… - Critical Reviews™ in …, 2000 - dl.begellhouse.com
ABSTRACT B and T lymphocytes are the effectors of specific immunity. However, their
function is critically dependent on dendritic cells (DC). DC are professional antigen …
function is critically dependent on dendritic cells (DC). DC are professional antigen …
Reengineering dendritic cell‐based anti‐cancer vaccines
GK Koski, PA Cohen, RE Roses, S Xu… - Immunological …, 2008 - Wiley Online Library
Despite initial enthusiasm, dendritic cell (DC)‐based anti‐cancer vaccines have yet to live
up to their promise as one of the best hopes for generating effective anti‐tumor immunity …
up to their promise as one of the best hopes for generating effective anti‐tumor immunity …